This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEA6K0UO_M.jpg
AbbVie announced earnings per share of $2.92 on revenue of $13.86B. Analysts polled by Investing.com anticipated EPS of $2.85 on revenue of $13.69B.
AbbVie shares are down 3% from the beginning of the year, still down 8.73% from its 52 week high of $113.37 set on January 13. They are under-performing the S&P 500 which is up 1.87% from the start of the year.
AbbVie shares gained 1.59% in pre-market trade following the report.
AbbVie’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
